|
시장보고서
상품코드
1552956
산화 스트레스 어세이 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)Oxidative Stress Assays Market (Product Type, Flow Cytometry, High-content Screening, Label-free Detection, Microscopy, and Chromatography) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
산화 스트레스 어세이 시장 - 조사 범위
TMR의 조사 보고서 "세계 산화 스트레스 어세이 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사합니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 산화 스트레스 어세이 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 산화 스트레스 어세이 시장의 복합 연간 성장률(CAGR %)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 산화 스트레스 어세이 시장을 이해하고자 했습니다.
| 시장 스냅샷 | |
|---|---|
| 2023년 시장 규모 | 10억 달러 |
| 2034년 시장 규모 | 28억 달러 |
| CAGR | 9.4% |
이 보고서는 세계 산화 스트레스 어세이 시장의 경쟁 환경을 조사하고 있습니다. 세계 산화 스트레스 어세이 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되어 있습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등 세계 산화 스트레스 어세이 시장 기업의 속성은 이 보고서에서 다루고 있습니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
- 소개
- 개요
- 시장 역학
- 세계의 시장 분석과 예측 c
제5장 주요 인사이트
- 파이프라인 분석
- 주요 제품/브랜드 분석
- 주요 M&A
- COVID-19에 의한 산업에 대한 영향
제6장 세계의 시장 분석과 예측 : 제품 유형별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 제품 유형별, 2020-2034년
- 소모품
- 키트·시약
- 기기
- 서비스
- 시장 매력 : 제품 유형별
제7장 세계의 시장 분석과 예측 : 테스트 유형별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 테스트 유형별, 2020-2034년
- 항산화능 어세이
- 아스코르브산 어세이
- 글루타티온 어세이
- 세포 기반 외인성항산화물질 어세이
- 간접 어세이
- 지질 기반 어세이
- 핵산 기반 어세이
- 단백질 기반 어세이
- 효소 기반 어세이
- 활성 산소종 기반 어세이
- 시장 매력 : 테스트 유형별
제8장 세계의 시장 분석과 예측 : 기술별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 기술별, 2020-2034년
- 효소면역측정법(ELISA)
- 유세포 분석
- HCS(High Content Screening)(HCS)
- 무표지 검출
- 현미경 검사
- 크로마토그래피
- 시장 매력 : 기술별
제9장 세계의 시장 분석과 예측 : 질환 유형별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 질환 유형별, 2020-2034년
- 심혈관질환
- 당뇨병
- 암
- 호흡기질환
- 기타(희귀질환 등)
- 시장 매력 : 질병 유형별
제10장 세계의 시장 분석과 예측 : 최종사용자별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 최종사용자별, 2020-2034년
- 임상 검사실
- CRO
- 바이오의약품 기업
- 학술·연구기관
- 시장 매력 : 최종사용자별
제11장 세계의 시장 분석과 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별, 2020-2034년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 시장 매력 : 지역별
제12장 북미의 시장 분석과 예측
제13장 유럽의 시장 분석과 예측
제14장 아시아태평양의 시장 분석과 예측
제15장 라틴아메리카의 시장 분석과 예측
제16장 중동 및 아프리카의 시장 분석과 예측
제17장 경쟁 상황
- 시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
- 시장 점유율 분석 : 기업별(2023)
- 기업 개요
- Abcam Ltd.
- AMSBIO
- BioVision, an Abcam Company
- Cell Biolabs Inc
- Enzo Life Sciences
- Merck KGaA
- ImmunoChemistry Technologies, LLC
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific
Oxidative Stress Assays Market - Scope of Report
TMR's report on the global oxidative stress assays market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global oxidative stress assays market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oxidative stress assays market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oxidative stress assays market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 1 Bn |
| Market Value in 2034 | US$ 2.8 Bn |
| CAGR | 9.4% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oxidative stress assays market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oxidative stress assays market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oxidative stress assays market.
The report delves into the competitive landscape of the global oxidative stress assays market. Key players operating in the global oxidative stress assays market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oxidative stress assays market profiled in this report.
Key Questions Answered in Global oxidative stress assays Market Report:
- What is the sales/revenue generated by oxidative stress assays across all regions during the forecast period?
- What are the opportunities in the global oxidative stress assays market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Oxidative Stress Assays Market - Research Objectives and Research Approach
The comprehensive report on the global oxidative stress assays market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global oxidative stress assays market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oxidative stress assays market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oxidative Stress Assays Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Oxidative Stress Assays Market Analysis and Forecast, 2020-2034
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Oxidative Stress Assays Market Analysis and Forecast, by Product Type
- 6.1. Introduction and Definitions
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product Type, 2020-2034
- 6.3.1. Consumables
- 6.3.2. Kits and Reagents
- 6.3.3. Instruments
- 6.3.4. Services
- 6.4. Market Attractiveness, by Product Type
7. Global Oxidative Stress Assays Market Analysis and Forecast, by Test Type
- 7.1. Introduction and Definitions
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Test Type, 2020-2034
- 7.3.1. Antioxidant Capacity Assays
- 7.3.2. Ascorbic Acid Assays
- 7.3.3. Glutathione Assays
- 7.3.4. Cell-based Exogenous Antioxidant Assays
- 7.3.5. Indirect Assays
- 7.3.6. Lipid-based Assays
- 7.3.7. Nucleic Acid-based Assays
- 7.3.8. Protein-based Assays
- 7.3.9. Enzyme-based Assays
- 7.3.10. Reactive Oxygen Species-based Assays
- 7.4. Market Attractiveness, by Test Type
8. Global Oxidative Stress Assays Market Analysis and Forecast, By Technology
- 8.1. Introduction and Definitions
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, By Technology, 2020-2034
- 8.3.1. Enzyme-linked Immunosorbent Assay (ELISA)
- 8.3.2. Flow Cytometry
- 8.3.3. High-content Screening (HCS)
- 8.3.4. Label-free Detection
- 8.3.5. Microscopy
- 8.3.6. Chromatography
- 8.4. Market Attractiveness, By Technology
9. Global Oxidative Stress Assays Market Analysis and Forecast, by Disease Type
- 9.1. Introduction and Definitions
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by Disease Type, 2020-2034
- 9.3.1. Cardiovascular Disease
- 9.3.2. Diabetes
- 9.3.3. Cancer
- 9.3.4. Respiratory Diseases
- 9.3.5. Others (Rare Disorders, etc.)
- 9.4. Market Attractiveness, by Disease Type
10. Global Oxidative Stress Assays Market Analysis and Forecast, by End-user
- 10.1. Introduction and Definitions
- 10.2. Key Findings/Developments
- 10.3. Market Value Forecast, by End-user, 2020-2034
- 10.3.1. Clinical Laboratories
- 10.3.2. Contract Research Organizations
- 10.3.3. Biopharmaceutical Companies
- 10.3.4. Academic & Research Organizations
- 10.4. Market Attractiveness, by End-user
11. Global Oxidative Stress Assays Market Analysis and Forecast, by Region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Region, 2020-2034
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
- 11.3. Market Attractiveness, by Region
12. North America Oxidative Stress Assays Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product Type, 2020-2034
- 12.2.1. Consumables
- 12.2.2. Kits and Reagents
- 12.2.3. Instruments
- 12.2.4. Services
- 12.3. Market Attractiveness, by Product Type
- 12.4. Market Value Forecast, by Test Type, 2020-2034
- 12.4.1. Antioxidant Capacity Assays
- 12.4.2. Ascorbic Acid Assays
- 12.4.3. Glutathione Assays
- 12.4.4. Cell-based Exogenous Antioxidant Assays
- 12.4.5. Indirect Assays
- 12.4.6. Lipid-based Assays
- 12.4.7. Nucleic Acid-based Assays
- 12.4.8. Protein-based Assays
- 12.4.9. Enzyme-based Assays
- 12.4.10. Reactive Oxygen Species-based Assays
- 12.5. Market Attractiveness, by Test Type
- 12.6. Market Value Forecast, By Technology, 2020-2034
- 12.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
- 12.6.2. Flow Cytometry
- 12.6.3. High-content Screening (HCS)
- 12.6.4. Label-free Detection
- 12.6.5. Microscopy
- 12.6.6. Chromatography
- 12.7. Market Attractiveness, By Technology
- 12.8. Market Value Forecast, by Disease Type, 2020-2034
- 12.8.1. Cardiovascular Disease
- 12.8.2. Diabetes
- 12.8.3. Cancer
- 12.8.4. Respiratory Diseases
- 12.8.5. Others (Rare Disorders, etc.)
- 12.9. Market Attractiveness, by Disease Type
- 12.10. Market Value Forecast, by End-user, 2020-2034
- 12.10.1. Clinical Laboratories
- 12.10.2. Contract Research Organizations
- 12.10.3. Biopharmaceutical Companies
- 12.10.4. Academic & Research Organizations
- 12.11. Market Attractiveness, by End-user
- 12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.12.1. U.S.
- 12.12.2. Canada
- 12.13. Market Attractiveness Analysis
- 12.13.1. By Product Type
- 12.13.2. By Test Type
- 12.13.3. By Technology
- 12.13.4. By Disease Type
- 12.13.5. By End-user
- 12.13.6. By Country
13. Europe Oxidative Stress Assays Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Product Type, 2020-2034
- 13.2.1. Consumables
- 13.2.2. Kits and Reagents
- 13.2.3. Instruments
- 13.2.4. Services
- 13.3. Market Attractiveness, by Product Type
- 13.4. Market Value Forecast, by Test Type, 2020-2034
- 13.4.1. Antioxidant Capacity Assays
- 13.4.2. Ascorbic Acid Assays
- 13.4.3. Glutathione Assays
- 13.4.4. Cell-based Exogenous Antioxidant Assays
- 13.4.5. Indirect Assays
- 13.4.6. Lipid-based Assays
- 13.4.7. Nucleic Acid-based Assays
- 13.4.8. Protein-based Assays
- 13.4.9. Enzyme-based Assays
- 13.4.10. Reactive Oxygen Species-based Assays
- 13.5. Market Attractiveness, by Test Type
- 13.6. Market Value Forecast, By Technology, 2020-2034
- 13.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
- 13.6.2. Flow Cytometry
- 13.6.3. High-content Screening (HCS)
- 13.6.4. Label-free Detection
- 13.6.5. Microscopy
- 13.6.6. Chromatography
- 13.7. Market Attractiveness, By Technology
- 13.8. Market Value Forecast, by Disease Type, 2020-2034
- 13.8.1. Cardiovascular Disease
- 13.8.2. Diabetes
- 13.8.3. Cancer
- 13.8.4. Respiratory Diseases
- 13.8.5. Others (Rare Disorders, etc.)
- 13.9. Market Attractiveness, by Disease Type
- 13.10. Market Value Forecast, by End-user, 2020-2034
- 13.10.1. Clinical Laboratories
- 13.10.2. Contract Research Organizations
- 13.10.3. Biopharmaceutical Companies
- 13.10.4. Academic & Research Organizations
- 13.11. Market Attractiveness, by End-user
- 13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.12.1. Germany
- 13.12.2. U.K.
- 13.12.3. France
- 13.12.4. Italy
- 13.12.5. Spain
- 13.12.6. Rest of Europe
- 13.13. Market Attractiveness Analysis
- 13.13.1. By Product Type
- 13.13.2. By Test Type
- 13.13.3. By Technology
- 13.13.4. By Disease Type
- 13.13.5. By End-user
- 13.13.6. By Country/Sub-region
14. Asia Pacific Oxidative Stress Assays Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Product Type, 2020-2034
- 14.2.1. Consumables
- 14.2.2. Kits and Reagents
- 14.2.3. Instruments
- 14.2.4. Services
- 14.3. Market Attractiveness, by Product Type
- 14.4. Market Value Forecast, by Test Type, 2020-2034
- 14.4.1. Antioxidant Capacity Assays
- 14.4.2. Ascorbic Acid Assays
- 14.4.3. Glutathione Assays
- 14.4.4. Cell-based Exogenous Antioxidant Assays
- 14.4.5. Indirect Assays
- 14.4.6. Lipid-based Assays
- 14.4.7. Nucleic Acid-based Assays
- 14.4.8. Protein-based Assays
- 14.4.9. Enzyme-based Assays
- 14.4.10. Reactive Oxygen Species-based Assays
- 14.5. Market Attractiveness, by Test Type
- 14.6. Market Value Forecast, By Technology, 2020-2034
- 14.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
- 14.6.2. Flow Cytometry
- 14.6.3. High-content Screening (HCS)
- 14.6.4. Label-free Detection
- 14.6.5. Microscopy
- 14.6.6. Chromatography
- 14.7. Market Attractiveness, By Technology
- 14.8. Market Value Forecast, by Disease Type, 2020-2034
- 14.8.1. Cardiovascular Disease
- 14.8.2. Diabetes
- 14.8.3. Cancer
- 14.8.4. Respiratory Diseases
- 14.8.5. Others (Rare Disorders, etc.)
- 14.9. Market Attractiveness, by Disease Type
- 14.10. Market Value Forecast, by End-user, 2020-2034
- 14.10.1. Clinical Laboratories
- 14.10.2. Contract Research Organizations
- 14.10.3. Biopharmaceutical Companies
- 14.10.4. Academic & Research Organizations
- 14.11. Market Attractiveness, by End-user
- 14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.12.1. China
- 14.12.2. Japan
- 14.12.3. India
- 14.12.4. Australia & New Zealand
- 14.12.5. Rest of Asia Pacific
- 14.13. Market Attractiveness Analysis
- 14.13.1. By Product Type
- 14.13.2. By Test Type
- 14.13.3. By Technology
- 14.13.4. By Disease Type
- 14.13.5. By End-user
- 14.13.6. By Country/Sub-region
15. Latin America Oxidative Stress Assays Market Analysis and Forecast
- 15.1. Introduction
- 15.1.1. Key Findings
- 15.2. Market Value Forecast, by Product Type, 2020-2034
- 15.2.1. Consumables
- 15.2.2. Kits and Reagents
- 15.2.3. Instruments
- 15.2.4. Services
- 15.3. Market Attractiveness, by Product Type
- 15.4. Market Value Forecast, by Test Type, 2020-2034
- 15.4.1. Antioxidant Capacity Assays
- 15.4.2. Ascorbic Acid Assays
- 15.4.3. Glutathione Assays
- 15.4.4. Cell-based Exogenous Antioxidant Assays
- 15.4.5. Indirect Assays
- 15.4.6. Lipid-based Assays
- 15.4.7. Nucleic Acid-based Assays
- 15.4.8. Protein-based Assays
- 15.4.9. Enzyme-based Assays
- 15.4.10. Reactive Oxygen Species-based Assays
- 15.5. Market Attractiveness, by Test Type
- 15.6. Market Value Forecast, By Technology, 2020-2034
- 15.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
- 15.6.2. Flow Cytometry
- 15.6.3. High-content Screening (HCS)
- 15.6.4. Label-free Detection
- 15.6.5. Microscopy
- 15.6.6. Chromatography
- 15.7. Market Attractiveness, By Technology
- 15.8. Market Value Forecast, by Disease Type, 2020-2034
- 15.8.1. Cardiovascular Disease
- 15.8.2. Diabetes
- 15.8.3. Cancer
- 15.8.4. Respiratory Diseases
- 15.8.5. Others (Rare Disorders, etc.)
- 15.9. Market Attractiveness, by Disease Type
- 15.10. Market Value Forecast, by End-user, 2020-2034
- 15.10.1. Clinical Laboratories
- 15.10.2. Contract Research Organizations
- 15.10.3. Biopharmaceutical Companies
- 15.10.4. Academic & Research Organizations
- 15.11. Market Attractiveness, by End-user
- 15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
- 15.12.1. Brazil
- 15.12.2. Mexico
- 15.12.3. Rest of Latin America
- 15.13. Market Attractiveness Analysis
- 15.13.1. By Product Type
- 15.13.2. By Test Type
- 15.13.3. By Technology
- 15.13.4. By Disease Type
- 15.13.5. By End-user
- 15.13.6. By Country/Sub-region
16. Middle East & Africa Oxidative Stress Assays Market Analysis and Forecast
- 16.1. Introduction
- 16.1.1. Key Findings
- 16.2. Market Value Forecast, by Product Type, 2020-2034
- 16.2.1. Consumables
- 16.2.2. Kits and Reagents
- 16.2.3. Instruments
- 16.2.4. Services
- 16.3. Market Attractiveness, by Product Type
- 16.4. Market Value Forecast, by Test Type, 2020-2034
- 16.4.1. Antioxidant Capacity Assays
- 16.4.2. Ascorbic Acid Assays
- 16.4.3. Glutathione Assays
- 16.4.4. Cell-based Exogenous Antioxidant Assays
- 16.4.5. Indirect Assays
- 16.4.6. Lipid-based Assays
- 16.4.7. Nucleic Acid-based Assays
- 16.4.8. Protein-based Assays
- 16.4.9. Enzyme-based Assays
- 16.4.10. Reactive Oxygen Species-based Assays
- 16.5. Market Attractiveness, by Test Type
- 16.6. Market Value Forecast, By Technology, 2020-2034
- 16.6.1. Cardiovascular Disease
- 16.6.2. Diabetes
- 16.6.3. Cancer
- 16.6.4. Respiratory Diseases
- 16.6.5. Others (Rare Disorders, etc.)
- 16.6.6. Market Attractiveness, By Technology
- 16.7. Market Value Forecast, by Disease Type, 2020-2034
- 16.7.1. Companion Animal
- 16.7.2. Livestock Animal
- 16.8. Market Attractiveness, by Disease Type
- 16.9. Market Value Forecast, by End-user, 2020-2034
- 16.9.1. Clinical Laboratories
- 16.9.2. Contract Research Organizations
- 16.9.3. Biopharmaceutical Companies
- 16.9.4. Academic & Research Organizations
- 16.10. Market Attractiveness, by End-user
- 16.11. Market Value Forecast, by Country/Sub-region, 2020-2034
- 16.11.1. GCC Countries
- 16.11.2. South Africa
- 16.11.3. Rest of Middle East & Africa
- 16.12. Market Attractiveness Analysis
- 16.12.1. By Product Type
- 16.12.2. By Test Type
- 16.12.3. By Technology
- 16.12.4. By Disease Type
- 16.12.5. By End-user
- 16.12.6. By Country/Sub-region
17. Competition Landscape
- 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 17.2. Market Share Analysis, by Company (2023)
- 17.3. Company Profiles
- 17.3.1. Abcam Ltd.
- 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.1.2. Product Portfolio
- 17.3.1.3. Financial Overview
- 17.3.1.4. SWOT Analysis
- 17.3.1.5. Strategic Overview
- 17.3.2. AMSBIO
- 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.2.2. Product Portfolio
- 17.3.2.3. Financial Overview
- 17.3.2.4. SWOT Analysis
- 17.3.2.5. Strategic Overview
- 17.3.3. BioVision, an Abcam Company
- 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.3.2. Product Portfolio
- 17.3.3.3. Financial Overview
- 17.3.3.4. SWOT Analysis
- 17.3.3.5. Strategic Overview
- 17.3.4. Cell Biolabs Inc
- 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.4.2. Product Portfolio
- 17.3.4.3. Financial Overview
- 17.3.4.4. SWOT Analysis
- 17.3.4.5. Strategic Overview
- 17.3.5. Enzo Life Sciences
- 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.5.2. Product Portfolio
- 17.3.5.3. Financial Overview
- 17.3.5.4. SWOT Analysis
- 17.3.5.5. Strategic Overview
- 17.3.6. Merck KGaA
- 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.6.2. Product Portfolio
- 17.3.6.3. Financial Overview
- 17.3.6.4. SWOT Analysis
- 17.3.6.5. Strategic Overview
- 17.3.7. ImmunoChemistry Technologies, LLC
- 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.7.2. Product Portfolio
- 17.3.7.3. Financial Overview
- 17.3.7.4. SWOT Analysis
- 17.3.7.5. Strategic Overview
- 17.3.8. Promega Corporation
- 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.8.2. Product Portfolio
- 17.3.8.3. Financial Overview
- 17.3.8.4. SWOT Analysis
- 17.3.8.5. Strategic Overview
- 17.3.9. Qiagen N.V.
- 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.9.2. Product Portfolio
- 17.3.9.3. Financial Overview
- 17.3.9.4. SWOT Analysis
- 17.3.9.5. Strategic Overview
- 17.3.10. Thermo Fisher Scientific
- 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.10.2. Product Portfolio
- 17.3.10.3. Financial Overview
- 17.3.10.4. SWOT Analysis
- 17.3.10.5. Strategic Overview
- 17.3.1. Abcam Ltd.
샘플 요청 목록